The Central Government has informed the Supreme Court of India that it has decided to cap trade margins on anti-cancer medicines at 30% of their maximum retail price (MRP). The Supreme Court, however, has called for a broader review of Read more…
The Central Government has informed the Supreme Court of India that it has decided to cap trade margins on anti-cancer medicines at 30% of their maximum retail price (MRP). The Supreme Court, however, has called for a broader review of Read more…